M Hebbar Selected Research

M Hebbar Research Topics

Disease

10	Colorectal Neoplasms (Colorectal Cancer) 02/2016 - 03/2005
7	Neoplasms (Cancer) 03/2013 - 01/2000
6	Neoplasm Metastasis (Metastasis) 02/2016 - 01/2000
5	Breast Neoplasms (Breast Cancer) 04/2003 - 01/2000
3	Adenocarcinoma 01/2017 - 12/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 03/2013
3	Hepatocellular Carcinoma (Hepatoma) 12/2012 - 08/2008
2	Diarrhea 12/2011 - 01/2010
2	Neutropenia 01/2010 - 01/2005
2	Vomiting 01/2010 - 01/2005
2	Anemia 01/2010 - 01/2005
2	Pulmonary Hypertension 10/2001 - 09/2001
2	Sclerosis 03/2001 - 04/2000
1	Pain (Aches) 06/2015
1	Fibrosis (Cirrhosis) 12/2012
1	Disease Progression 12/2011
1	Chronic Disease (Chronic Diseases) 01/2010
1	Fatigue 01/2010
1	Abdominal Pain (Pain, Abdominal) 01/2005
1	Leukopenia 01/2005
1	Thrombocytopenia (Thrombopenia) 01/2005
1	Phlebitis 01/2005
1	Asthenia 01/2005
1	Carcinoma (Carcinomatosis) 01/2005
1	Giant Cell Arteritis (Horton Disease) 10/2002
1	CREST Syndrome (Syndrome, CREST) 10/2001
1	Cicatrix (Scar) 04/2000
1	Systemic Scleroderma (Systemic Sclerosis) 04/2000
1	Ulcer 04/2000
1	Rheumatoid Arthritis 01/2000
1	Virus Diseases (Viral Diseases) 01/2000

Drug/Important Bio-Agent (IBA)

5	Leucovorin (Folinic Acid)FDA Link 02/2015 - 01/2006
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2015 - 01/2006
4	Fluorouracil (Carac)FDA LinkGeneric 02/2015 - 01/2007
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2015 - 01/2010
2	Cetuximab (Erbitux)FDA Link 02/2016 - 03/2010
2	Gemcitabine FDA Link 06/2015 - 03/2013
2	XELOXIBA 01/2010 - 01/2010
2	Capecitabine (Xeloda)FDA Link 01/2010 - 01/2010
2	beta-Galactoside alpha-2,3-SialyltransferaseIBA 04/2003 - 01/2000
2	SteroidsIBA 04/2003 - 10/2002
2	SelectinsIBA 04/2003 - 01/2000
2	E-SelectinIBA 04/2003 - 01/2000
2	SialyltransferasesIBA 04/2003 - 01/2000
2	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 04/2003 - 01/2000
1	folfirinoxIBA 01/2017
1	masitinibIBA 06/2015
1	Acyl-CoA OxidaseIBA 06/2015
1	MucinsIBA 03/2013
1	DeoxycytidineIBA 03/2013
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 03/2013
1	Small Interfering RNA (siRNA)IBA 03/2013
1	Sorafenib (BAY 43-9006)FDA Link 11/2011
1	Bevacizumab (Avastin)FDA Link 03/2010
1	Transaminases (Aminotransferases)IBA 01/2010
1	Pemetrexed (MTA)FDA Link 01/2010
1	Docetaxel (Taxotere)FDA Link 08/2008
1	Celecoxib (Celebrex)FDA Link 01/2007
1	UracilIBA 01/2006
1	TegafurIBA 01/2006
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2005
1	EnzymesIBA 01/2005
1	raltitrexed (D 1694)IBA 01/2005
1	Hormones (Hormone)IBA 04/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2002
1	Iloprost (Ventavis)FDA Link 10/2001
1	Anticardiolipin AntibodiesIBA 09/2001
1	Nerve Growth Factor (NGF)IBA 06/2001
1	Steroid Receptors (Steroid Receptor)IBA 06/2001
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 06/2001
1	Antinuclear AntibodiesIBA 03/2001
1	ErbB Receptors (EGF Receptor)IBA 11/2000
1	Growth Factor ReceptorsIBA 11/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2000
1	Angiogenesis InhibitorsIBA 04/2000
1	EndostatinsIBA 04/2000
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2000
1	Penicillamine (Cuprimine)FDA Link 01/2000
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2000

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 02/2016 - 01/2006
4	Therapeutics 01/2010 - 10/2002
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Liver Transplantation 12/2012
1	Contraindications 12/2012
1	Folfox protocol 01/2010